Monocytes from patients with myelodysplastic syndromes are activated and their inhibitory effect on hematopoiesis can be overcome by blocking the CD40 receptor

被引：0
|
作者：
Meers, S.
Boon, L.
Lemmens, J.
Verfaillie, C.
Verhoef, G.
Delforge, M.
机构：
来源：
ACTA CLINICA BELGICA | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 32 条
  • [21] CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro
    Neron, Sonia
    Boire, Gilles
    Dussault, Nathalie
    Racine, Claudia
    de Brum-Fernandes, Artur J.
    Cote, Serge
    Jacques, Annie
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2009, 57 (06) : 447 - 458
  • [22] Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease
    Itoh, M
    Uchimura, K
    Makino, M
    Kobayashi, T
    Hayashi, R
    Nagata, M
    Kakizawa, H
    Fujiwara, K
    Nagasaka, A
    CYTOKINE, 2000, 12 (06) : 688 - 693
  • [23] Analysis of the thrombopoietin-receptor in CD34+ cells from patients with myelodysplastic syndromes using a full-length RT-PCR.
    Hofmann, WK
    Kalina, U
    Wagner, S
    Hoelzer, D
    Ottmann, OG
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 794 - 794
  • [24] Anti-CD40 upregulates significantly tumor necrosis factor-alpha production of macrophages from patients with myelodysplastic syndromes compared to healthy control subjects
    Meers, S
    Raets, V
    Boon, L
    Kasran, A
    Boogaerts, M
    Delforge, M
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 106 - 106
  • [25] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    CELL, 1993, 72 (02) : 291 - 300
  • [26] Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of Zwitterionic polysaccharides to induce T-cell stimulation
    Stephen, TL
    Niemeyer, M
    Tzianabos, AO
    Kroenke, M
    Kasper, DL
    Kalka-Moll, WM
    INFECTION AND IMMUNITY, 2005, 73 (04) : 2184 - 2189
  • [27] EFFECT OF THE NON-PEPTIDE THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG (PROMACTA®/REVOLADETM) ON BONE MARROW CELLS FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Will, B.
    Luciano, J. P.
    Kawahara, M.
    Erickson-Miller, C.
    Verma, A.
    Aivado, M.
    Steidl, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 71 - 71
  • [28] Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor κB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis
    Harigai, M
    Hara, M
    Kawamoto, M
    Kawaguchi, Y
    Sugiura, T
    Tanaka, M
    Nakagawa, M
    Ichida, H
    Takagi, K
    Higami-Ohsako, S
    Shimada, K
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2167 - 2177
  • [29] Neutrophils and Monocytes From Patients With CD40L Deficiency Present a Defective Respiratory Burst Response to Several Stimuli and This Defect Can Be Reversed By Exogenous IFN-Gamma
    Marques, O. C.
    Frazao, J.
    Pereira, P.
    Kubo, C.
    Falcai, A.
    Klaver, S.
    Errante, P.
    Fernandes, J.
    Weber, C.
    Rosario-Filho, N.
    Carvalho, B.
    Condino-Neto, J.
    CLINICAL IMMUNOLOGY, 2010, 135 (02) : 296 - 297
  • [30] Interferon-β Therapy May Exert a Neuroprotective Effect Via Upregulation of BDNF Secretion from PBMCs of RR-MS Patients through CD40 Dependent Mechanism
    Azoulay, David
    Fainberg, Karin
    Urshansky, Natoli
    Fahoum, Firas
    Korni, Arnon
    NEUROLOGY, 2009, 72 (11) : A36 - A36
1234